{
    "organizations": [],
    "uuid": "e68b41a49d06978616b0d9135b422a426e4be37c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-rexahn-pharmaceuticals-q1-loss-per/brief-rexahn-pharmaceuticals-q1-loss-per-share-0-07-idUSASC0A025",
    "ord_in_thread": 0,
    "title": "Rexahn Pharmaceuticals Q1 Loss Per Share $0.07",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Rexahn Pharmaceuticals Inc:\n* Q1 LOSS PER SHARE $0.07 * AS OF MAY 4, 2018, HAD $19.3 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS\n* EXPECTS CASH, CASH EQUIVALENTS, INVESTMENTS TO BE SUFFICIENT TO FUND CASH FLOW REQUIREMENTS INTO MID-2019 Source text for Eikon:\nOur ",
    "published": "2018-05-07T20:08:00.000+03:00",
    "crawled": "2018-05-08T16:49:38.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "rexahn",
        "pharmaceutical",
        "inc",
        "q1",
        "loss",
        "per",
        "share",
        "may",
        "million",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "expects",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "sufficient",
        "fund",
        "cash",
        "flow",
        "requirement",
        "source",
        "text",
        "eikon"
    ]
}